Copyright ©The Author(s) 2015.
World J Biol Chem. Aug 26, 2015; 6(3): 162-208
Published online Aug 26, 2015. doi: 10.4331/wjbc.v6.i3.162
Table 3 The deregulated expression of the canonical myomiRs in different cancers
MiR-1MiR-206MiR-133aMiR-133bCancer typeRef.
++Progressive bladder cancer (TCC)[122]
--Bladder cancer (TCC)[93,156]
---Bladder cancer (TCC)[92,144]
----Bladder cancer[127]1
----Bladder cancer[128]1
---Muscle-invasive bladder cancer[92]
-Proliferating breast cancer[108]
-ERα-positive breast cancer[109]
--Breast cancer[95]
+Progressive cervical carcinoma[117,121]
+Colon cancer[116]
-Colon cancer[101]
+/-Liver metastasis compared to primary CRC[118]
--Colon cancer[95]
--Progressive GIST[281]
-Laryngeal SCC cells[113]
++Liver cancer[95]
-Lung cancers: (NSCLC, adenocarcinomas, lung SCC, large cell carcinoma, and bronchoalveolar cell carcinoma)[100]
-High metastasis lung tumors[107]
-Lung SCC tissue; lung-SCC cell lines[115]
--Lung adenocarcinomas; NSCLC cells[99]
--Lung carcinomas[85,115,131]
--Lung cancer[95]
+Multiple myeloma[152]
+Progressive prostate cancer[123]
-(-)-Prostate cancer[102]
--Prostate cancer[95]
--Recurrent prostate cancer compared to non-recurrent cancer[96]
--Hormone-insensitive prostate cancer cells[102]
--Ovarian cancer[95]
--Testicular cancer[95]